TCL Archive In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept. August 8, 1975
TCL Archive In Brief Election Results Won’t Hurt Cancer Program, May Help; Coper To Stay If Carter Wants Him November 12, 1976
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal December 1, 1995
